![](https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2024/07/60-Degrees-shutterstock_1869676093-1.jpg)
60 Degrees Pharmaceuticals enters deals for babesiosis treatment trial
60 Degrees Pharmaceuticals has signed clinical trial agreements with three clinical trial sites to carry out the study of tafenoquine to treat babesiosis. Yale University, Tufts Medical Center and Rhode Island Hospital have started enrolling trial subjects …